PURPOSE: A Topoisomerase 1 (Top1) poison is frequently included in the treatment regimens for metastatic colorectal cancer (mCRC). However, no predictive biomarkers for Top1 poisons are available. We here report a study on the TOP1 gene copy number in CRC patients and its association with patient prognosis and tumor cell proliferation. EXPERIMENTAL DESIGN: The study included TOP1 and CEN-20 fluorescence in situ hybridization (FISH) analyses on formalin fixed paraffin embedded (FFPE) tissue sections from 154 stage III CRC chemonaïve patients. The frequencies of aberration in the TOP1 gene copy number, the CEN-20 copy number and the TOP1/CEN-20 ratio were analyzed and associated with overall survival (OS), time to recurrence (TTR) and in a subgroup analysis of rectal cancer patients only with time to local recurrence (LR in RC). Moreover, the TOP1 and CEN-20 copy numbers were correlated with the tumor Ki67 proliferation index. RESULTS: 35.7% of the tumors had an increased TOP1 copy number above 4n gene copies per cell and 28.6% and 9.7% had a TOP1/CEN-20 ratio ≥1.5 or ≥2.0, respectively. The TOP1 copy number and the TOP1/CEN-20 ratios were separately added into multivariate analyses as continuous variables, in which also age, gender, primary tumor location and Ki67 status were added as covariates. In contrast to the TOP1/CEN-20 ratio, the TOP1 copy number was significantly associated with OS (HR: 0.62; 95% CI: 0.42-0.90; p = 0.01). Neither the TOP1 copy number nor the ratio was significantly associated with TTR and only the TOP1/CEN-20 ratio was significantly associated with LR in RC (HR: 0.25; 95% CI: 0.08-0.83; p = 0.02). No significant correlation was found between the TOP1 copy number and proliferation, while a weak and inverse correlation between the CEN-20 copy number and proliferation was observed. CONCLUSIONS: This study showed that increased TOP1 gene copy numbers are frequent findings in cancer cells in stage III CRC tumors but unrelated to the proliferative status of the tumors. The association with prognosis is important to consider when planning and analyzing future studies investigating TOP1 as a potential predictive biomarker for Top1 poisons.
PURPOSE: A Topoisomerase 1 (Top1) poison is frequently included in the treatment regimens for metastatic colorectal cancer (mCRC). However, no predictive biomarkers for Top1 poisons are available. We here report a study on the TOP1 gene copy number in CRC patients and its association with patient prognosis and tumor cell proliferation. EXPERIMENTAL DESIGN: The study included TOP1 and CEN-20 fluorescence in situ hybridization (FISH) analyses on formalin fixed paraffin embedded (FFPE) tissue sections from 154 stage III CRC chemonaïve patients. The frequencies of aberration in the TOP1 gene copy number, the CEN-20 copy number and the TOP1/CEN-20 ratio were analyzed and associated with overall survival (OS), time to recurrence (TTR) and in a subgroup analysis of rectal cancerpatients only with time to local recurrence (LR in RC). Moreover, the TOP1 and CEN-20 copy numbers were correlated with the tumor Ki67 proliferation index. RESULTS: 35.7% of the tumors had an increased TOP1 copy number above 4n gene copies per cell and 28.6% and 9.7% had a TOP1/CEN-20 ratio ≥1.5 or ≥2.0, respectively. The TOP1 copy number and the TOP1/CEN-20 ratios were separately added into multivariate analyses as continuous variables, in which also age, gender, primary tumor location and Ki67 status were added as covariates. In contrast to the TOP1/CEN-20 ratio, the TOP1 copy number was significantly associated with OS (HR: 0.62; 95% CI: 0.42-0.90; p = 0.01). Neither the TOP1 copy number nor the ratio was significantly associated with TTR and only the TOP1/CEN-20 ratio was significantly associated with LR in RC (HR: 0.25; 95% CI: 0.08-0.83; p = 0.02). No significant correlation was found between the TOP1 copy number and proliferation, while a weak and inverse correlation between the CEN-20 copy number and proliferation was observed. CONCLUSIONS: This study showed that increased TOP1 gene copy numbers are frequent findings in cancer cells in stage III CRC tumors but unrelated to the proliferative status of the tumors. The association with prognosis is important to consider when planning and analyzing future studies investigating TOP1 as a potential predictive biomarker for Top1 poisons.
Authors: Miriam Koopman; Ninja F Antonini; Joep Douma; Jaap Wals; Aafke H Honkoop; Frans Lg Erdkamp; Robert S de Jong; Cees J Rodenburg; Gerard Vreugdenhil; Olaf Jl Loosveld; Aart van Bochove; Harm Am Sinnige; Geert-Jan M Creemers; Margot Et Tesselaar; Peter H Th J Slee; Marjon Jbp Werter; Linda Mol; Otilia Dalesio; Cornelis Ja Punt Journal: Lancet Date: 2007-07-14 Impact factor: 79.321
Authors: Lisa M McShane; Douglas G Altman; Willi Sauerbrei; Sheila E Taube; Massimo Gion; Gary M Clark Journal: Breast Cancer Res Treat Date: 2006-08-24 Impact factor: 4.872
Authors: Maria Unni Rømer; Niels Frank Jensen; Signe Lykke Nielsen; Sven Müller; Kirsten Vang Nielsen; Hans Jørgen Nielsen; Nils Brünner Journal: Scand J Gastroenterol Date: 2012-01 Impact factor: 2.423
Authors: Ann S Knoop; Helle Knudsen; Eva Balslev; Birgitte B Rasmussen; Jens Overgaard; Kirsten V Nielsen; Andreas Schonau; Katrín Gunnarsdóttir; Karen E Olsen; Henning Mouridsen; Bent Ejlertsen Journal: J Clin Oncol Date: 2005-10-20 Impact factor: 44.544
Authors: Michal Sheffer; Manny D Bacolod; Or Zuk; Sarah F Giardina; Hanna Pincas; Francis Barany; Philip B Paty; William L Gerald; Daniel A Notterman; Eytan Domany Journal: Proc Natl Acad Sci U S A Date: 2009-04-09 Impact factor: 11.205
Authors: Eric Van Cutsem; Roberto Labianca; György Bodoky; Carlo Barone; Enrique Aranda; Bernard Nordlinger; Claire Topham; Josep Tabernero; Thierry André; Alberto F Sobrero; Enrico Mini; Richard Greil; Francesco Di Costanzo; Laurence Collette; Laura Cisar; Xiaoxi Zhang; David Khayat; Carsten Bokemeyer; Arnaud D Roth; David Cunningham Journal: J Clin Oncol Date: 2009-05-18 Impact factor: 44.544
Authors: Dafna Tsafrir; Manny Bacolod; Zachariah Selvanayagam; Ilan Tsafrir; Jinru Shia; Zhaoshi Zeng; Hao Liu; Curtis Krier; Robert F Stengel; Francis Barany; William L Gerald; Philip B Paty; Eytan Domany; Daniel A Notterman Journal: Cancer Res Date: 2006-02-15 Impact factor: 12.701
Authors: Ron Firestein; Adam J Bass; So Young Kim; Ian F Dunn; Serena J Silver; Isil Guney; Ellen Freed; Azra H Ligon; Natalie Vena; Shuji Ogino; Milan G Chheda; Pablo Tamayo; Stephen Finn; Yashaswi Shrestha; Jesse S Boehm; Supriya Jain; Emeric Bojarski; Craig Mermel; Jordi Barretina; Jennifer A Chan; Jose Baselga; Josep Tabernero; David E Root; Charles S Fuchs; Massimo Loda; Ramesh A Shivdasani; Matthew Meyerson; William C Hahn Journal: Nature Date: 2008-09-14 Impact factor: 49.962
Authors: Michael S Braun; Susan D Richman; Philip Quirke; Catherine Daly; Julian W Adlard; Faye Elliott; Jennifer H Barrett; Peter Selby; Angela M Meade; Richard J Stephens; Mahesh K B Parmar; Matthew T Seymour Journal: J Clin Oncol Date: 2008-06-01 Impact factor: 44.544
Authors: Ida Marie Heeholm Sønderstrup; Sune Boris Nygård; Tim Svenstrup Poulsen; Dorte Linnemann; Jan Stenvang; Hans Jørgen Nielsen; Jiri Bartek; Nils Brünner; Peter Nørgaard; Lene Riis Journal: Mol Oncol Date: 2015-03-04 Impact factor: 6.603
Authors: Maria Unni Rømer; Sune Boris Nygård; Ib Jarle Christensen; Signe Lykke Nielsen; Kirsten Vang Nielsen; Sven Müller; David Hersi Smith; Ben Vainer; Hans Jørgen Nielsen; Nils Brünner Journal: Mol Oncol Date: 2012-10-11 Impact factor: 6.603
Authors: Jan Stenvang; Iben Kümler; Sune Boris Nygård; David Hersi Smith; Dorte Nielsen; Nils Brünner; José M A Moreira Journal: Front Oncol Date: 2013-12-25 Impact factor: 6.244
Authors: Vui King Vincent-Chong; Arif Anwar; Lee Peng Karen-Ng; Sok Ching Cheong; Yi-Hsin Yang; Padmaja Jayaprasad Pradeep; Zainal Ariff Abdul Rahman; Siti Mazlipah Ismail; Zuraiza Mohamad Zaini; Narayanan Prepageran; Thomas George Kallarakkal; Anand Ramanathan; Nur Aaina Binti Mohd Mohayadi; Nurul Shielawati Binti Mohamed Rosli; Wan Mahadzir Wan Mustafa; Mannil Thomas Abraham; Keng Kiong Tay; Rosnah Binti Zain Journal: PLoS One Date: 2013-02-06 Impact factor: 3.240
Authors: David Hersi Smith; Ib Jarle Christensen; Niels Frank Jensen; Bo Markussen; Maria Unni Rømer; Sune Boris Nygård; Sven Müller; Hans Jørgen Nielsen; Nils Brünner; Kirsten Vang Nielsen Journal: PLoS One Date: 2013-04-05 Impact factor: 3.240
Authors: David Hersi Smith; Ib Jarle Christensen; Niels Frank Jensen; Bo Markussen; Sven Müller; Hans Jørgen Nielsen; Nils Brünner; Kirsten Vang Nielsen Journal: BMC Cancer Date: 2013-10-21 Impact factor: 4.430